U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 12 results

Status:
US Approved Rx (2006)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftriaxone is a broad-spectrum cephalosporin antibiotic with a very long half-life. Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both ...
Status:
US Previously Marketed
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftizoxime is a semisynthetic cephalosporin antibiotic, which can be administered intravenously or intramuscularly. It was sold under brand name, cefizox, but was removed from the US Market in 2007. Cefizox was used to treat different infections, ...
Status:
US Previously Marketed
First approved in 1982

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefoperazone (marketed under the name Cefobid) is a third-generation cephalosporin antibiotic. Cefoperazone has a broad spectrum of activity: Respiratory Tract Infections caused by S. pneumoniae, H. influenzae, S. aureus (penicillinase and non-penici...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (RACEMIC)



Morinidazole is a novel third generation 5-nitroimidazole-class antimicrobial agent indicated for the treatment of anaerobic bacterial infections including appendicitis and pelvic inflammatory disease. Morinidazole is administered as a racemate. Mori...
Status:
US Approved Rx (2006)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftriaxone is a broad-spectrum cephalosporin antibiotic with a very long half-life. Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both ...
Status:
US Approved Rx (2006)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftriaxone is a broad-spectrum cephalosporin antibiotic with a very long half-life. Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both ...
Status:
US Approved Rx (2006)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftriaxone is a broad-spectrum cephalosporin antibiotic with a very long half-life. Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both ...
Status:
US Previously Marketed
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftizoxime is a semisynthetic cephalosporin antibiotic, which can be administered intravenously or intramuscularly. It was sold under brand name, cefizox, but was removed from the US Market in 2007. Cefizox was used to treat different infections, ...
Status:
US Previously Marketed
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftizoxime is a semisynthetic cephalosporin antibiotic, which can be administered intravenously or intramuscularly. It was sold under brand name, cefizox, but was removed from the US Market in 2007. Cefizox was used to treat different infections, ...
Status:
US Previously Marketed
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftizoxime is a semisynthetic cephalosporin antibiotic, which can be administered intravenously or intramuscularly. It was sold under brand name, cefizox, but was removed from the US Market in 2007. Cefizox was used to treat different infections, ...

Showing 1 - 10 of 12 results